- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wockhardt Limited — Board Meeting, 03-11-2025: Outcome of Board Meeting
03-11-2025 | 02:55 pm
03-11-2025 | 02:55 pm
Wockhardt's board approved Q2/H1 consolidated results. A major strategic move: the company is exiting its US generic pharma business, resulting in a Rs 97 Cr exceptional charge. Also, Mr. Om Prakash Bhatt joins as an Independent Director.
No comments yet. Be the first to comment!